Personalis Inc (NASDAQ:PSNL)
| 1.65 Delayed Data As of Nov 28 |  -0.15 / -8.33%Today’s Change | 0.89 Today|||52-Week Range 4.31 | -16.67% Year-to-Date |
Latest PSNL News | Press Releases
No recent news for Personalis Inc.
Today’s Trading
| Previous close | 1.80 |
| Today’s open | 1.84 |
| Day’s range | 1.53 - 1.84 |
| Volume | 62,448 |
| Average volume (3 months) | 359,777 |
| Market cap | $77.2M |
Data as of 3:59pm ET, 11/28/2023
Growth & Valuation
| Earnings growth (last year) | -66.82% |
| Earnings growth (this year) | +11.19% |
| Earnings growth (next 5 years) | -13.78% |
| Revenue growth (last year) | -23.92% |
| P/E ratio | NM |
| Price/Sales | 1.39 |
| Price/Book | 0.34 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| IFRXInflaRx NV | -0.01 | -1.07% |
| NKTRNektar Therapeutics | -0.02 | -3.56% |
| ADVMAdverum Biotechnolog... | -0.03 | -3.61% |
| ---- |
Data as of 4:00pm ET, 11/28/2023
Financials
| Next reporting date | February 22, 2024 |
| EPS forecast (this quarter) | -$0.55 |
| Annual revenue (last year) | $65.0M |
| Annual profit (last year) | -$113.3M |
| Net profit margin | -174.20% |
Profile
Sector Health Services |
Industry Medical/Nursing Services |
No executives to display |
Corporate headquarters Fremont, California |
Forecasts
